Patent · US Expired

Muteins of human erythropoietin, the preparation thereof and the use thereof

US5457089A · kind A · utility

43Cited by

2References

4Claims

0Family size

Assignee

Behringwerke Aktiengesellschaft · DE

Inventors

Mathias Fibi · Marburg, DE
Gerd Zettlmeissl · Lahntal, DE
Hans Kupper · Marburg, DE

Key dates

Filing date	Jul 6, 1994
Grant date	Oct 10, 1995
Priority date	—
Expiry date	Jul 6, 2014

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to muteins of human erythropoietin (EPO) in the carboxyl terminal region which are prepared by means of recombinant DNA techniques. These mutants have advantageous properties in comparison with human wild-type EPO.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.